Gibt es fallzahlabhängige Effekte auf Behandlungsangebote für Patienten mit einem Peniskarzinom? Ergebnisse einer Umfrage an Universitätsklinika in Deutschland und Österreich
Steffen Lebentrau(Medizinische Hochschule Brandenburg Theodor Fontane), Matthias May(Barmherzige Brüder Klinikum St. Elisabeth in Straubing), Semih Sarcan(University Hospital Schleswig-Holstein), Ingmar Wolff(Universitätsmedizin Greifswald), Lukas Lusuardi(Paracelsus Medical University), Jens Wiegland(Barmherzige Brüder Klinikum St. Elisabeth in Straubing), Christian Thomas(Hôpital des Diaconesses), Christain Gilfrich(Barmherzige Brüder Klinikum St. Elisabeth in Straubing), Axel S. Merseburger(Universitäres Kinderwunschzentrum Lübeck), Maximilian Burger(University of Regensburg), Abdulbaki Yakac(University Hospital Carl Gustav Carus)
Cited by 2
Related Papers
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene Alteration
|Journal of Clinical Oncology|2020|676
The Effect of Exercise Training Programs on Bone Mass: A Meta-analysis of Published Controlled Trials in Pre- and Postmenopausal Women
|Osteoporosis International|1999|594
Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort
|European Urology|2014|206
Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study
|European Urology|2008|178
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer
|Clinical Cancer Research|2016|113